Malignant Anorectal Neoplasm — Trials

Malignant Anorectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,783 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 452
Recruiting: 249
Ph III recruiting: 38
Growth YoY: +8.5%
Industry share: 6%
Top sponsor: Fudan University
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (174)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06014944	Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody(PMMR/MSS)	not yet recruiting	Phase 2	30	Changhai HospitalOTHER	0	Aug 31, 2023	clinicaltrials
NCT05998122	Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study	not yet recruiting	Phase 2	45	The First Hospital of Jilin UniversityOTHER